Literature DB >> 15911117

No association between common variations in the human alpha 2 subunit gene (ATP1A2) of the sodium-potassium-transporting ATPase and idiopathic generalized epilepsy.

Falk W Lohoff1, Thomas N Ferraro, Thomas Sander, Hongyu Zhao, John P Dahl, Wade H Berrettini, Russell J Buono.   

Abstract

Quantitative trait loci studies in inbred mice have identified a locus on chromosome 1 (Szs1) of fundamental importance to seizure susceptibility. High-ranking candidate genes in this susceptibility region include KCNJ9, KCNJ10 and ATP1A2. We performed a systematic mutation scan of the coding region of the human ATP1A2 gene and performed a case-control association study with seven common markers. Genotypes were assessed in 152 idiopathic generalized epilepsy (IGE) patients of German ancestry and 111 healthy German controls for all seven polymorphisms. No significant differences were found in genotype or allele frequencies for any of the variations between the IGE patients and controls. No haplotypes were associated with IGE when compared to controls. Linkage disequilibrium was demonstrated throughout the gene. Results suggest that the polymorphisms we studied in the ATP1A2 gene do not represent major susceptibility factors for common forms of IGE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911117     DOI: 10.1016/j.neulet.2005.02.057

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells.

Authors:  Stuart G Gillies; Kate Haddley; Sylvia A Vasiliou; Gregory M Jacobson; Bengt von Mentzer; Vivien J Bubb; John P Quinn
Journal:  J Mol Neurosci       Date:  2010-07-23       Impact factor: 3.444

2.  Genetic control of a central pattern generator: rhythmic oromotor movement in mice is controlled by a major locus near Atp1a2.

Authors:  John D Boughter; Megan K Mulligan; Steven J St John; Kenichi Tokita; Lu Lu; Detlef H Heck; Robert W Williams
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.